-
Nina Jasmin Hewing
From the Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York; the
-
Gisela Weskamp
From the Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York; the
-
Joost Vermaat
Departments of Ophthalmology and
Molecular Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; the
-
Eric Farage
Departments of Ophthalmology and
Molecular Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; the
-
Krzysztof Glomski
From the Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York; the
Biochemistry, Cell and Molecular Biology Program, Weill Medical College of Cornell University, New York, New York; the
-
Steven Swendeman
From the Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York; the
-
Robison Vernon Paul Chan
Department of Ophthalmology, Weill Medical College of Cornell University, New York, New York; the
-
Michael F. Chiang
Departments of Ophthalmology and Medical Informatics and Clinical Epidemiology, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon; the
-
Rama Khokha
Department of Medical Biophysics, Ontario Cancer Institute, Toronto, Ontario, Canada; and the
-
Bela Anand-Apte
Molecular Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; the
-
Carl Peter Blobel
From the Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York; the
Departments of Ophthalmology and
Departments of Medicine and Physiology, Biophysics and Systems Biology, Weill Medical College of Cornell University, New York, New York.